I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| B cell | 40 studies | 43% ± 13% | |
| plasmacytoid dendritic cell | 30 studies | 84% ± 18% | |
| conventional dendritic cell | 26 studies | 37% ± 19% | |
| macrophage | 24 studies | 28% ± 10% | |
| memory B cell | 20 studies | 47% ± 14% | |
| naive B cell | 20 studies | 45% ± 12% | |
| dendritic cell | 13 studies | 40% ± 21% | |
| monocyte | 11 studies | 25% ± 9% | |
| natural killer cell | 11 studies | 29% ± 11% | |
| classical monocyte | 11 studies | 28% ± 14% | |
| non-classical monocyte | 11 studies | 27% ± 10% | |
| microglial cell | 11 studies | 31% ± 12% | |
| myeloid cell | 9 studies | 33% ± 11% | |
| alveolar macrophage | 6 studies | 20% ± 4% | |
| CD16-negative, CD56-bright natural killer cell, human | 6 studies | 30% ± 9% | |
| immature B cell | 6 studies | 47% ± 5% | |
| mononuclear phagocyte | 5 studies | 39% ± 20% | |
| CD16-positive, CD56-dim natural killer cell, human | 5 studies | 21% ± 5% | |
| leukocyte | 4 studies | 31% ± 5% | |
| precursor B cell | 4 studies | 35% ± 10% | |
| germinal center B cell | 4 studies | 55% ± 17% | |
| endothelial cell of lymphatic vessel | 3 studies | 20% ± 3% | |
| hematopoietic precursor cell | 3 studies | 43% ± 23% |
